India · Delayed Price · Currency is INR NSE:INDRAMEDCO Statistics
Total Valuation
NSE:INDRAMEDCO has a market cap or net worth of INR 34.30 billion. The enterprise value is 32.04 billion.
| Market Cap | 34.30B |
| Enterprise Value | 32.04B |
Important Dates
The last earnings date was Tuesday, May 12, 2026.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | Sep 18, 2025 |
Share Statistics
NSE:INDRAMEDCO has 91.67 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 91.67M |
| Shares Outstanding | 91.67M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -0.08% |
| Owned by Insiders (%) | 2.90% |
| Owned by Institutions (%) | 5.05% |
| Float | 40.99M |
Valuation Ratios
The trailing PE ratio is 18.68 and the forward PE ratio is 16.58.
| PE Ratio | 18.68 |
| Forward PE | 16.58 |
| PS Ratio | 2.31 |
| PB Ratio | 4.63 |
| P/TBV Ratio | 4.63 |
| P/FCF Ratio | 31.82 |
| P/OCF Ratio | 20.48 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.00, with an EV/FCF ratio of 29.72.
| EV / Earnings | 17.45 |
| EV / Sales | 2.16 |
| EV / EBITDA | 12.00 |
| EV / EBIT | 14.35 |
| EV / FCF | 29.72 |
Financial Position
The company has a current ratio of 2.46, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.46 |
| Quick Ratio | 2.27 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.34 |
| Interest Coverage | 37.09 |
Financial Efficiency
Return on equity (ROE) is 27.47% and return on invested capital (ROIC) is 44.91%.
| Return on Equity (ROE) | 27.47% |
| Return on Assets (ROA) | 15.14% |
| Return on Invested Capital (ROIC) | 44.91% |
| Return on Capital Employed (ROCE) | 27.17% |
| Weighted Average Cost of Capital (WACC) | 7.14% |
| Revenue Per Employee | 4.88M |
| Profits Per Employee | 605,008 |
| Employee Count | 3,035 |
| Asset Turnover | 1.61 |
| Inventory Turnover | 125.70 |
Taxes
In the past 12 months, NSE:INDRAMEDCO has paid 624.00 million in taxes.
| Income Tax | 624.00M |
| Effective Tax Rate | 25.36% |
Stock Price Statistics
The stock price has decreased by -15.18% in the last 52 weeks. The beta is 0.52, so NSE:INDRAMEDCO's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -15.18% |
| 50-Day Moving Average | 398.53 |
| 200-Day Moving Average | 449.72 |
| Relative Strength Index (RSI) | 44.39 |
| Average Volume (20 Days) | 429,233 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:INDRAMEDCO had revenue of INR 14.83 billion and earned 1.84 billion in profits. Earnings per share was 20.03.
| Revenue | 14.83B |
| Gross Profit | 5.49B |
| Operating Income | 2.23B |
| Pretax Income | 2.46B |
| Net Income | 1.84B |
| EBITDA | 2.67B |
| EBIT | 2.23B |
| Earnings Per Share (EPS) | 20.03 |
Balance Sheet
The company has 2.63 billion in cash and 368.60 million in debt, with a net cash position of 2.26 billion or 24.70 per share.
| Cash & Cash Equivalents | 2.63B |
| Total Debt | 368.60M |
| Net Cash | 2.26B |
| Net Cash Per Share | 24.70 |
| Equity (Book Value) | 7.40B |
| Book Value Per Share | 80.78 |
| Working Capital | 2.47B |
Cash Flow
In the last 12 months, operating cash flow was 1.67 billion and capital expenditures -596.50 million, giving a free cash flow of 1.08 billion.
| Operating Cash Flow | 1.67B |
| Capital Expenditures | -596.50M |
| Depreciation & Amortization | 436.30M |
| Net Borrowing | -24.30M |
| Free Cash Flow | 1.08B |
| FCF Per Share | 11.76 |
Margins
Gross margin is 37.04%, with operating and profit margins of 15.06% and 12.39%.
| Gross Margin | 37.04% |
| Operating Margin | 15.06% |
| Pretax Margin | 16.59% |
| Profit Margin | 12.39% |
| EBITDA Margin | 18.00% |
| EBIT Margin | 15.06% |
| FCF Margin | 7.27% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 1.05%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 1.05% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 22.35% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 1.05% |
| Earnings Yield | 5.35% |
| FCF Yield | 3.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |